Date | Title | Description | Source |
22.03.2024 | Lenmeldy Sparks Controversy as World's Most Expensive Medici... | Inno Flores, Tech Times 22 March 2024, 09:03 pm
The introduction of Lenmeldy has sparked debates ove... | techtimes.... |
18.03.2024 | Gene Therapy Is Now First FDA-Approved Treatment for Rare &a... | A genetic medicine at the heart of a $387 million Kyowa Kirin acquisition has won FDA approval, a re... | medcitynew... |
18.03.2024 | FDA greenlights Orchard’s gene therapy Lenmeldy for rare and... | - | fprimecapi... |
13.11.2023 | Orchard Therapeutics Reports Third Quarter 2023 Financial Re... | Reported $5.6 million in quarterly Libmeldy net revenue and $12.7 million year-to-date
Planned acqui... | einpresswi... |
08.03.2023 | Orchard Therapeutics announces strategic financing totalling... | | ucltf.co.u... |
06.03.2023 | Orchard Therapeutics Announces Strategic Financing Totalling... | - | globenewsw... |
05.01.2023 | Orchard Therapeutics Announces U.S. FDA Clearance of IND App... | BOSTON and LONDON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics ORTX, a global gene therap... | einpresswi... |
21.12.2022 | Gene therapy trial shows promise for treating ‘bubble boy’ s... | H.T. Begay is a happy kid. He’s smiley, silly, and definitely trying to make you laugh. The four-yea... | statnews.c... |
13.01.2022 | J.P. Morgan 2022: Reaching New Heights, Looking to New Horiz... | Reaching New Heights, Looking to New Horizons
Bobby Gaspar, M.D., Ph.D., chief executive officer
40t... | marketscre... |
05.11.2021 | Investor Deck – November 2021 | Corporate Presentation
November 2021
Forward-looking Statements
Certain information set forth in thi... | marketscre... |
12.08.2021 | In rare disease research, patient-centered clinical trial de... | Since the introduction of the 21st Century Cures Act nearly five years ago, policymakers, regulators... | statnews.c... |
01.07.2021 | Orchard Therapeutics : and Pharming HAE Collaboration | Joint analyst call: Orchard Therapeutics & Pharming Group
Dr Sijmen de Vries, CEO, Pharming Grou... | marketscre... |
03.03.2021 | Be The Match BioTherapies® Announces Expansion of Multi-Year... | MINNEAPOLIS--(BUSINESS WIRE)--Mar 3, 2021--
Be The Match BioTherapies, an organization offering solu... | oaoa.com/n... |
05.02.2021 | Orchard Therapeutics Announces $150 Million Strategic Financ... | - | fprimecapi... |
22.12.2020 | Orchard Therapeutics Receives EC Approval for Treatment of E... | LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm fo... | 4biocapita... |
15.07.2020 | Biohaven recruits a Kardashian to help sell migraine dr... | → Biohaven has enlisted the help of Khloé Kardashian to help promote their newly approved mi... | endpts.com... |
10.10.2019 | Female founders are more likely than men to attract later-st... | Female founders are more likely than men to attract later-stage venture capital funding, according t... | sifted.eu/... |
16.04.2019 | Data Supports Achievement of Proof-of-Concept Milestone for ... | Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from t... | ucltf.co.u... |
11.04.2019 | 10 successful female-led tech startups from London which got... | Women entrepreneurs are increasing in number unlike ever before. They have busted stereotypes and ar... | siliconcan... |
28.02.2019 | Orchard Therapeutics achieves 100% survival rate during tria... | ADA-SCID is a rare, life-threatening, inherited disease caused by mutations in the ADA gene. Patient... | ucltf.co.u... |
22.02.2019 | 4BIO portfolio company Orchard Therapeutics announces ADA-SC... | Orchard Therapeutics plc (Nasdaq:ORTX) presents Two-Year Follow-Up Data versus historical control fr... | 4biocapita... |
05.11.2018 | Orchard Therapeutics Announces Closing of $225 Million Initi... | - | fprimecapi... |
05.11.2018 | Orchard Therapeutics Closes $225M Initial Public Offering | Orchard Therapeutics plc (Nasdaq: ORTX), a Boston, Mass., USA and London, UK-based biopharmaceutical... | finsmes.co... |
05.11.2018 | Orchard Therapeutics announces closing of $225 Million Initi... | - | ucltf.co.u... |
01.11.2018 | Orchard Therapeutics Prices Initial Public Offering | Orchard Therapeutics plc (Nasdaq: ORTX), a biopharmaceutical company dedicated to improving the cond... | finsmes.co... |
05.10.2018 | Two months after closing a Series C round, Orchard Therapeut... | In April, Orchard acquired British drugmaker GlaxoSmithKline’s rare disease gene therapy portfolio, ... | medcitynew... |
05.10.2018 | Orchard Therapeutics plans $172.5 million U.S. IPO | - | fprimecapi... |
15.08.2018 | Term Sheet — Wednesday, August 15 | IPO COMING SOON
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see F... | fortune.co... |
14.08.2018 | Orchard Therapeutics Nabs $150M Series C |
BOSTON, MA, Orchard Therapeutics has raised a further $150 million to fund its work in gene therap... | vcnewsdail... |
13.08.2018 | Orchard Therapeutics closes $150 million Series C round | The company plans to use the money to advance its three leading clinical programs, namely OTL-101 fo... | medcitynew... |
13.08.2018 | Orchard Therapeutics Raises $150M in Series C Financing | Orchard Therapeutics, a London, United Kingdom-based company developing gene therapies, completed a ... | finsmes.co... |
13.08.2018 | 4BIO portfolio company Orchard Therapeutics Announces $150 M... | Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of pati... | 4biocapita... |
13.08.2018 | Orchard Therapeutics Announces $150 Million Series C Financi... | - | fprimecapi... |
20.12.2017 | 4BIO Capital participates in $110M Series B Financing of Orc... | Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with r... | 4biocapita... |
20.12.2017 | Orchard Therapeutics Raises $110M in Series B Financing | Orchard Therapeutics, a London, UK- and California, US-based biotechnology company dedicated to trea... | finsmes.co... |
20.12.2017 | Orchard Therapeutics raises $110m from Baillie Gifford, ORI ... | Premium
Orchard Therapeutics said on Wednesday it raised $110 million in the second round of funding... | dealstreet... |
03.05.2016 | Orchard Therapeutics launches, raises $33M, will face off wi... | Orchard Therapeutics burst into life today with a little seed money and backing from several major h... | fiercebiot... |
03.05.2016 | Orchard Therapeutics launches with £21-million series A fund... | As part of its launch, Orchard Therapeutics' has announced formal partnerships with UCL, Great Ormon... | ucltf.co.u... |
- | Considerations in commercializing HSC gene therapies for rar... | By Braden Parker, Chief Commercial Officer
This article was originally published as a Guest Column o... | statnews.c... |
- | Two months after closing a Series C round, Orchard Therapeut... | A company that markets the first gene therapy to win European Medicines Agency approval has filed fo... | medcitynew... |
- | The genetic medicine revolution is here — it’s time to build... | Gene and cell therapy have moved from the realm of science fiction to medical reality. These new the... | statnews.c... |
- | Orchard Therapeutics closes $150 million Series C round | A company developing gene therapies for rare disorders has raised a large round of financing only mo... | medcitynew... |
- | On the frontier of gene therapy, new possibilities emerge | Researchers investigating a potential new therapy for an ultra-rare genetic disease have made an imp... | statnews.c... |
- | Evolving the Newborn Screening system is key to realizing th... | There are an estimated 7,000 rare diseases known today — a disproportionate number of which impact i... | statnews.c... |